Navigation Links
Stem cells show promise for treating infertility in cancer patients
Date:11/1/2012

AUDIO: This is an audio clip of Deborah Sweet of Cell Stem Cell interviewing Dr. Kyle Orwig of the University of Pittsburgh School of Medicine regarding his recent preclinical study "Spermatogonial...

Click here for more information.

A promising stem-cell-based approach for treating infertility has been successfully demonstrated in non-human primates, as reported in a study published by Cell Press in the November issue of the journal Cell Stem Cell. The preclinical study represents an important milestone for translating this strategy to the clinic, particularly for cancer survivors who have been rendered infertile by chemotherapy they received before reaching sexual maturity.

"This is the first study to demonstrate that transplanted spermatogonial stem cells can produce functional sperm in higher primates," says senior study author Kyle Orwig of the University of Pittsburgh and Magee-Womens Research Institute. "This is an important step toward human translation."

Cancer patients who undergo radiation therapy or chemotherapy often become infertile because these treatments damage dividing cells, including not only cancer cells but also spermatogonial stem cells (SSCs)stem cells that develop into sperm. Prior to cancer therapy, adult men can cryopreserve their sperm and later use these cells to father children. But prepubertal boys don't have this option because they have not yet produced any mature sperm, so cancer treatments can leave them permanently infertile.

One promising strategy for these young patients is to preserve their SSCs before they undergo cancer therapy and later transplant these cells after they finish cancer treatment and reach sexual maturity. This approach has worked in a range of animal models, but past studies in large animals have primarily used radiation therapy to cause infertility, even though chemotherapy is also a common source of infertility in cancer patients.

In the new study, Orwig and his team cryopreserved SSCs from monkeys before treating them with a commonly used chemotherapy drug. After treatment, they injected the SSCs into the testes of these animals and found that the cells produced sperm in the majority of transplant recipients. Moreover, the SSC-derived sperm of one animal was capable of fertilizing egg cells and producing embryos that developed normally.

As noted in the accompanying In Translation article by Pierre Fouchet and colleagues, this work "constitutes a milestone in the field of reproduction, and generates hope for restoring fertility in survivors of childhood cancer."


'/>"/>

Contact: Elisabeth (Lisa) Lyons
elyons@cell.com
617-386-2121
Cell Press
Source:Eurekalert

Related medicine news :

1. A protein’s role in helping cells repair DNA damage
2. Scientists create endless supply of myelin-forming cells
3. Stem Cells to Cartilage? Promising Results Seen in Mice
4. Scientists decode software instructions of aggressive leukemia cells
5. New options for ease and accuracy in extraction of rare cells or separating blood
6. Stimulating brain cells with light
7. Research identifies protein that regulates key fate decision in cortical progenitor cells
8. UGA researchers boost efficacy of drugs by using nanoparticles to target powerhouse of cells
9. At the right place at the right time -- new insights into muscle stem cells
10. Lack of oxygen in cancer cells leads to growth and metastasis
11. Human Stem Cells Restore Hearing to Deaf Gerbils in Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Rock, AR (PRWEB) , ... October 13, 2017 ... ... firm with locations throughout Arkansas that offers insurance and financial preparation services, is ... benefit the Rock City Rescue organization. , Rock City Rescue is a locally ...
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to take ... an inventor from Austin, Texas, has identified a solution. , She developed a prototype ... restricted lighting. As such, it eliminates the need to turn on a light when ...
(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... EDWARDSVILLE, Ill. (PRWEB) , ... ... ... University Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and ... educated healthcare professionals on guideline updates for the primary prevention of cardiovascular ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Apple Rehab ... services, staged a mock evacuation of the facility as part of a disaster drill ... Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, Inc. ... Day Software and Consulting, LLC , and named its ... Software, based in Tennessee , will ... Day expands EnvoyHealth,s service offerings for health care partners ... "In an interoperable world, ...
(Date:9/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... and webcast on Friday, November 3, 2017, beginning at ... at approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... financial performance and guidance for 2018, Hill-Rom executives will ... operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: